Moreover, persistent STAT3 activation contributes to tumor survival, tumor metastasis, and inflammation while inhibiting antitumor immunity via a mechanism mediated by the NF-κB and Janus kinase pathways [20]. The gene discussed is NFKB1; the disease is neoplasm.